Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP419890.RAnT61iN2hdGCN9oASvpPGS-LFr7FbUdd6nvDcDmF4gXU130_assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419890.RAnT61iN2hdGCN9oASvpPGS-LFr7FbUdd6nvDcDmF4gXU130_provenance.
• NP720017.RATjXxajyC9T3lUrVbGQ9t10FjI4f44h7pqouMF2pwHNA130_assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP720017.RATjXxajyC9T3lUrVbGQ9t10FjI4f44h7pqouMF2pwHNA130_provenance.
• assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP634915.RAJBunpOGpESoxfl2tZA4y32aLBvkKa8gU-pK5nP0AI7g130_assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634915.RAJBunpOGpESoxfl2tZA4y32aLBvkKa8gU-pK5nP0AI7g130_provenance.
• assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP466007.RAkAj5ZUG29aoG1J1a0i8HmQOg2MKfTdIVHyiyn6cy3QY130_assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP466007.RAkAj5ZUG29aoG1J1a0i8HmQOg2MKfTdIVHyiyn6cy3QY130_provenance.
• NP253123.RAfJowh3NaGT041RobQtezksNba9nmnW4pA3AfktjM8-E130_assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253123.RAfJowh3NaGT041RobQtezksNba9nmnW4pA3AfktjM8-E130_provenance.
• NP253127.RAlEOpyGPBxXc48c-sKmRU26OrYR2FkLcBbMGBI72xyu4130_assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253127.RAlEOpyGPBxXc48c-sKmRU26OrYR2FkLcBbMGBI72xyu4130_provenance.
• NP824338.RAIA4ifWPCm3pxtKz0foETpKhedDEWjwh80fYpn6v6k2U130_assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP824338.RAIA4ifWPCm3pxtKz0foETpKhedDEWjwh80fYpn6v6k2U130_provenance.
• NP253124.RANt3sgxIhH9ns9buXQTekzCx1On7Bt52Ei48RiXG39m4130_assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253124.RANt3sgxIhH9ns9buXQTekzCx1On7Bt52Ei48RiXG39m4130_provenance.
• NP253126.RAOLYifRcoFpj-3ccsn6J7qsYbEdZODlMm_Sl-rsVBrkw130_assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253126.RAOLYifRcoFpj-3ccsn6J7qsYbEdZODlMm_Sl-rsVBrkw130_provenance.
• NP673669.RA3c3R-iLrU_NytJxzDybMR_Rh8o43TV2OLWYFxOpHkxs130_assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673669.RA3c3R-iLrU_NytJxzDybMR_Rh8o43TV2OLWYFxOpHkxs130_provenance.
• NP253125.RA48LDKz9Loi9qCDw7k4qCW1c-AG2RI7KEukmcU_kswjY130_assertion description "[In congenital 11beta-HSD deficiency and after administration of 11beta-HSD inhibitors, suppression of 11beta-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253125.RA48LDKz9Loi9qCDw7k4qCW1c-AG2RI7KEukmcU_kswjY130_provenance.